Predict your next investment

Aiyi Hema company logo
CONSUMER PRODUCTS & SERVICES | Education & Training (non-internet/mobile) / Training Services
ayhmjy.com

See what CB Insights has to offer

Investors Count

3

Aiyi Hema Funding, Aiyi Hema Valuation & Aiyi Hema Revenue

2 Fundings

Aiyi Hema's latest funding round was a Series B for on November 20, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/20/2018

Series B

$0.00B

((9.99x))

FY 1234

6

2/1/2017

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

11/20/2018

2/1/2017

Round

Series B

Series A

Amount

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

6

10

Aiyi Hema Investors

3 Investors

Aiyi Hema has 3 investors. Hina Group invested in Aiyi Hema's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/20/2018

11/20/2018

1
Series B

Private Equity

China

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

China

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Asset/Investment Management

China

First funding

11/20/2018

00/00/0000

00/00/0000

Last Funding

11/20/2018

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Private Equity

Venture Capital

Asset/Investment Management

Location

China

China

China

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.